Prof. Dr. Sibel Ertek Yalçın

Research Assistant
Ankara Numune Training and Research Hospital, Department of General Surgery, 1st General Surgery Clinic – 2000

Research Assistant
Ankara University Faculty of Medicine, Department of Internal Medicine – 2000–2005

Specialist Physician
Ankara Çağ Hospital, Department of Internal Medicine – 2005

Specialist Physician
Ankara University Faculty of Medicine, Division of Nephrology – 2005–2006

Specialist Physician
Başkent University Faculty of Medicine, Division of Nephrology – 2006

Specialist Physician
Ankara Güven Hospital, Department of Internal Medicine – 2006–2008

Specialist Physician
University of Bologna, Department of Internal Medicine, “D.Campanacci” (Bologna/Italy) – 2006

PhD Program – Special Student
Hacettepe University, Faculty of Medicine, Department of Pharmacology – 2007–2008

Subspecialty Training
Ufuk University Faculty of Medicine, Dr. Rıdvan Ege Hospital, Division of Endocrinology and Metabolism Diseases – 2008–2011

Specialist Physician (compulsory service)
Şanlıurfa Training and Research Hospital, Division of Endocrinology and Metabolism Diseases – 2011–2012

Specialist Physician
Medicalpark Antalya Organ Transplantation Center and Hospital, Endocrinology and Metabolism Diseases – 2012–2013

Specialist Physician, Associate Professor
Koru Hospital, Endocrinology and Metabolism Diseases, Ankara – 2013–2014

Associate Professor
Memorial Ankara Hospital, Endocrinology and Metabolism Diseases – 2014–2018

Associate Professor
Medicalpark Ankara Hospital, Endocrinology and Metabolism Diseases – 2019

Professor
Medicalpark Ankara Hospital, Endocrinology and Metabolism Diseases / İstinye University Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism Diseases – November 2019

A. Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

A1. Borghi C, Ertek S, Cicero AF.
Irbesartan: A review of its use alone and in combination with hydrochlorothiazide.
Therapy, 2006; 6: 733–749.

A2. Borghi C, Ertek S.
LIFE (Losartan Intervention for Endpoint Reduction in Hypertension) study and its substudies.
International Congress Series, 2007; 1303: 129–137.

A3. Cicero AF, Ertek S.
Natural sources of antidyslipidaemic agents: Is there an evidence-based approach for their prescription?
Mediterr J Nutr Metab, 2008; 1: 85–93.

A4. Ertek S, Erdoğan G.
Postpartum thyroiditis and hypothalamo-hypophysial insufficiency in the same woman with successive pregnancies: A case report.
Gynecol Endocrinol, 2009; Aug 22: 1–4.

A5. Ertek S, Torun AN, Ateş K.
The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.
Int Urol Nephrol, 2010; 42: 211–218.

A6. Aylı M, Ertek S.
Serious venous thromboembolism, heterozygous factor V Leiden and prothrombin G20210A mutations in a case with Klinefelter Syndrome and type 2 diabetes.
Int Med, 2009; 48: 1681–1685.

A7. Ertek S, Cicero AF, Çağlar O, Erdoğan G.
Relationship between serum zinc levels, thyroid hormones and thyroid volume following successful iodine supplementation.
Hormones, 2010; 9(3): 262–268.

A8. Cicero AF, Ertek S, Borghi C.
Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management.
Curr Vasc Pharmacol, 2009; 7(3): 330–337.

A9. Cicero AF, Ertek S.
Berberine: Metabolic and cardiovascular effects in preclinical and clinical trials.
Clinical Lipidology, 2009; 4: 553–563.

A10. Ozbalkan Z, Efe C, Cesur M, Ertek S, Nasıroğlu N, Berneis K, Rizzo M.
An update on relationships between rheumatoid arthritis and atherosclerosis.
Atherosclerosis, 2010; 212: 377–382.

A11. Akgül E, Kutuk U, Ertek S, Cesur M, Cehreli S, Töre HF, Erdoğan G.
Cardiac autonomic function and global left ventricular performance in autoimmune euthyroid chronic thyroiditis: Is treatment necessary at the euthyroid stage?
Echocardiography, 2011; 28: 15–21.

A12. Ertek S, Cicero AF, Cesur M, Akçil M, Altuner Kayhan T, Avcıoğlu U, Korkmaz ME.
The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography.
Acta Diabetol, 2011; 48: 21–27.

A13. Cicero AF, Ertek S.
Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans.
Arch Med Sci, 2010; 6: 469–477.

A14. Akgül Ercan E, Ertek S, İş G, Çağlar O, Öztaş E, Cicero AF, Alhan A, Cehreli S, Töre HF, Erdoğan G.
Factors associated with increased carotid intima-media thickness and being nondipper in nonobese and normotensive young patients affected by PCOS.
Angiology, 2011; 62: 543–548.

A15. Cicero AF, Ertek S.
Hypertension and diabetes incidence: Confounding factors.
Hypertens Res, 2011; 34: 1069–1070.

A16. Ertek S, Cicero AF, Erdoğan G.
The relationship between calcium metabolism, insulin-like growth factor-1 and pulse pressure in normotensive, normolipidemic and nondiabetic subjects.
Arch Med Sci, 2011; 7: 776–780.

A17. Ertek S, Akgül E, Cicero AF, Kutuk U, Demirtaş S, Cehreli S, Erdoğan G.
25-hydroxy vitamin D levels and endothelial vasodilator function in normotensive women.
Arch Med Sci, 2012; 8: 47–52.

A18. Ertek S, Ersoy RU, Anıl C, Demir O, Erdoğan MF, Güllü S, Berker D, Gül K, Ünlütürk U, Erdoğan G.
Hypothyroidism, new nodule formation, and increase in nodule size in patients who have undergone hemithyroidectomy.
Arch Med Sci, 2012; 8: 214–217.

A19. Ertek S, Yılmaz NC, Cicero AF, Vurupalmaz O, Demiröz AS, Erdoğan G.
Increasing diagnosis of thyroid papillary carcinoma follicular variant in South-East Anatolian region.

A19. Ertek S, Yılmaz NC, Cicero AF, Vurupalmaz O, Demiröz AS, Erdoğan G.
Comparison of characteristics of classical papillary and follicular variant thyroid cancers.
Endocr Pathol, 2012; 23(3): 157–160. (Web of Science: Q2)

A20. Cicero AF, Ferroni A, Ertek S.
Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.
Expert Opin Drug Saf, 2012; 11(5): 753–766. (Web of Science: Q1)

A21. Akpınar EE, Akpınar S, Ertek S, Sayın E, Gülhan M.
Systemic inflammation and metabolic syndrome in stable COPD patients.
Tuberk Toraks, 2012; 60: 230–237. (Web of Science: Q3)

A22. Ertek S, Cicero AF.
Impact of physical activity on inflammation: Effects on cardiovascular disease risk and other inflammatory conditions.
Arch Med Sci, 2012; 8(5): 794–804. (Web of Science: Q1)

A23. Cicero AF, Tartagni E, Ertek S.
Metformin and its clinical use: New insights for an old drug in clinical practice.
Arch Med Sci, 2012; 8(5): 907–917. (Web of Science: Q1)

Doçentlikten Sonra Eklenen Uluslararası Yayınlar

A24. Ertek S, Banach M.
Editorial: The changing face of metabolic syndrome and its components in the light of current knowledge.
Curr Vasc Pharmacol, 2014; 12(4): 549–552. (Web of Science: Q2)

A25. Ertek S, Çetinkalp S.
Is there U-turn from insulin back to pills in diabetes?
Curr Vasc Pharmacol, 2014; 12(4): 617–626. (Web of Science: Q2)

A26. Çetinkalp S, Simsir İY, Ertek S.
Insulin resistance in brain and possible therapeutic approaches.
Curr Vasc Pharmacol, 2014; 12(4): 553–564. (Web of Science: Q2)

A27. Cicero AF, Tartagni E, Ertek S.
Nutraceuticals for metabolic syndrome management: From laboratory to benchside.
Curr Vasc Pharmacol, 2014; 12(4): 565–571. (Web of Science: Q2)

A28. Ertek S, Cicero AF.
Hyperthyroidism and cardiovascular complications: A narrative review on the basis of pathophysiology.
Arch Med Sci, 2013; 9(5): 944–952. (Web of Science: Q1)

A29. Cesur M, Akçil M, Ertek S, Emral R, Bulut S, Güllü S, Çorapçıoğlu D.
Role of cytological characteristics of benign thyroid nodules on effectiveness of their treatment with levothyroxine.
Arch Med Sci, 2013; 9(6): 1083–1089. (Web of Science: Q1)

A30. Cicero AF, Tartagni E, Ertek S.
Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: The available clinical evidence.
Expert Opin Biol Ther, 2014; 14(6): 863–868. (Web of Science: Q1)

A31. Cicero AF, Tartagni E, Ertek S.
Safety and tolerability of injectable lipid-lowering drugs: A review of available clinical data.
Expert Opin Drug Saf, 2014; 13(8): 1023–1030. (Web of Science: Q1)

A32. Erdoğan G, Pabuçcu R, Ertek S, Israel S, Yılmaz B, Yılmaz H, Çağlar G.
Late-onset congenital adrenal hyperplasia with Cushing syndrome.
Intern Med, 2014; 53(17): 1955–1959. (Web of Science: Q3)

A33. Erdoğan MF, Demir Ö, Ersoy RÜ, Gül K, Aydoğan Bİ, Üç ZA, Mete T, Ertek S, Ünlütürk U, Çakır B, Aral Y, Güler S, Güllü S, Çorapçıoğlu D, Dağdelen S, Erdoğan G.
Comparison of early total thyroidectomy with antithyroid treatment in patients with moderate-severe Graves' orbitopathy: A randomized prospective trial.
Eur Thyroid J, 2016; 5(2): 106–111.

A34. Ertek S.
High-density lipoprotein (HDL) dysfunction and the future of HDL.
Curr Vasc Pharmacol, 2018; 16(5): 490–498. (Web of Science: Q2)

A35. Sönmez A, Haymana C, Bayram F, Salman S, Dizdar OS, Gürkan E, Kargılı Çarlıoğlu A, Barçın C, Sabuncu T, Satman I; TEMD Study Group.
Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Study).
Diabetes Res Clin Pract, 2018; 146: 138–147. (Web of Science: Q1)

A36. Sönmez A, Taşçı I, Demirci I, Haymana C, Barçın C, Aydın H, Çetinkalp S, Öztürk FY, Gül K, Sabuncu T, Satman I, Bayram F; TEMD Study Group.
A cross-sectional study of overtreatment and deintensification of antidiabetic and antihypertensive medications in diabetes mellitus: The TEMD overtreatment study.
Diabetes Ther, 2020; 11(5): 1045–1059.

A37. Bayram F, Sönmez A, Haymana C, Sabuncu T, Dizdar OS, Gürkan E, Çarlıoğlu AK, Ağbaht K, Özdemir D, Demirci I, Barçın C, Salman S, Tetiker T, Balcı MK, Kebapçı N, …

37. Bayram F, Sönmez A, Haymana C, Sabuncu T, Dizdar OS, Gürkan E, Çarlıoğlu AK, Ağbaht K, Özdemir D, Demirci I, Barçın C, Salman S, Tetiker T, Balcı MK, Kebapçı N, Ersoy C, Yumuk V, Toth PP, Satman I; TEMD Study Group.
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes: A nationwide cross-sectional study (TEMD dyslipidemia study).
Lipids Health Dis, 2020; 19(1): 237.

A38. Ertek S.
Molecular economy of nature with two thyrotropins from different parts of the pituitary: Pars tuberalis thyroid-stimulating hormone and pars distalis thyroid-stimulating hormone.
Arch Med Sci, 2021; 17(1): 189–195.

A39. De Matteis A, Türkmen Ceylan FB, Adrianopoli M, Ertek S.
The contribution of testing in the fight against COVID-19: Evidence from Italy.
Eur J Public Health, 2021; ckab064.

B. Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında (Proceedings) Basılan Bildiriler

B1. Uyar M, Sezer S, Arat Z, Özdemir NF, Ertek S, Haberal M.
Serum ghrelin levels in patients receiving renal replacement therapy.
XLIII ERA-EDTA Congress, 2006; Glasgow, United Kingdom.

B2. Sezer S, Altun A, Ertek S, Arat Z, Özdemir NF, Haberal M.
Pamidronate is safe and efficient in hypercalcemic hemodialysis patients.
XLIII ERA-EDTA Congress, 2006; Glasgow, United Kingdom.

B3. Çoban S, Ormeci N, Yolcu OF, Ertuğrul I, Ekiz F, Ertek S, Ülker A, Palabıyıkoğlu M.
The utility of serum MMP-3 in degree of activity in inflammatory bowel disease.
Inflammatory Bowel Disease: Diagnostic and Therapeutic Strategies Symposium, June 2006; Moscow, Russia.

B4. Ormeci N, Yolcu OF, Çoban S, Ertuğrul I, Ekiz F, Ertek S, Palabıyıkoğlu M, Ülker A.
The value of serum TGF-beta1 in degree of activity in inflammatory bowel disease.
IBD 2007 Achievements in Research and Clinical Practice, May 2007; İstanbul, Turkey.

B5. Ertek S, Cesur M, Cicero AF, Akçil M, Avcıoğlu U, Kayhan TA, Korkmaz ME.
Glycohemoglobin levels in non-diabetic patients and its relationship with metabolic syndrome criteria and pulse pressure.
77th Congress of the European Society of Atherosclerosis (EAS), April 2008; İstanbul, Turkey.

B6. Ertek S, Cicero AF, Cesur M, Avcıoğlu U, Altuner T.
Coronary atherosclerosis staging in patients diagnosed by different definitions of metabolic syndrome.
77th Congress of the European Society of Atherosclerosis (EAS), April 2008; İstanbul, Turkey.

B7. Ertek S, Cicero AF, Çağlar O, Erdoğan G.
Serum zinc levels and thyroid volume and thyroid tests in Turkish population after successful iodization.
Annual Meeting of the European Thyroid Association (ETA), September 2009; Lisbon, Portugal.

B8. Ertek S, Cicero AF, Erdoğan G.
Relationship between calcium metabolism and blood pressure: Effects of parathormone levels in healthy normocalcemic subjects.
IOF-WCO-ECCEO (International Osteoporosis Foundation – World Congress on Osteoporosis / 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis), May 2010; Florence, Italy.

B9. Akpınar EE, Akpınar S, Ertek S, Sayın E, Gülhan M.
Metabolic syndrome in patients with stable COPD (chronic obstructive lung disease).
European Respiratory Society (ERS) Annual Congress, September 2010; Barcelona, Spain.

B10. Çağlar O, Sancak T, Ertek S.
Comparison of thyroid fine needle aspiration biopsy results and efficiency of diffusion-weighted MRI in differentiating malignant and benign thyroid nodules.
European Congress of Radiology, March 2011; Vienna, Austria.

B11. Ertek S, Akgül E, Cicero AF, Cehreli S, Erdoğan G.
Can low vitamin D levels in summer be associated with decreased endothelial vasodilator function in normotensive, normolipidemic women?
European Society of Hypertension (ESH), July 2011; Milan, Italy.

B12. Ertek S, Akgül E, Cicero AF, Cehreli S, Erdoğan G.
Factors associated with increased carotid intima-media thickness and being non-dipper on 24-hour ambulatory blood pressure in non-obese normotensive young patients affected by PCOS.
European Society of Hypertension (ESH), July 2011; Milan, Italy.

B13. Ertek S, Cicero AF, Erdoğan G.
Predictors of blood pressure change in gestational diabetes treated with diet or insulin: A case-control study.
22nd European Meeting on Hypertension and Cardiovascular Prevention, April 2012; London, United Kingdom.

C. Yazılan Tanınmış Kitaplarda Bölümler

C.1. Uluslararası Kitaplarda Bölümler

C.1.1. Cicero AF, Ertek S.
Rice Bran Oil.
In: Rice: Production, Consumption, and Health Benefits.
Editors: Yoshihiro Liu, Liliana Froyen.
Nova Science Publishers, Inc.; 2012. New York.

C.1.2. Cesur M, Ertek S, Sayın İ.
Complications of Hyperthyroidism.
In: Thyroid Disorders – Focus on Hyperthyroidism.
Editor: Gonzalo Diaz Soto.
InTech; 2014.
ISBN: 978-953-51-1384-3
DOI: 10.5772/58196 (Kitap DOI: 10.5772/57001)

C.1.3. Valentinuzzi ME, Ertek S, Zanutto BS.
The Future of Bioengineering: Possible New Areas.
In: Further Understanding of the Human Machine: The Road to Bioengineering.
Editor: Valentinuzzi ME.
World Scientific Publishing; ISBN-13: 978-9813147256 / ISBN-10: 9813147253.

C.2. Yurtiçinde Basılmış Kitaplarda Bölümler

C.2.1. Gündoğdu S, Kadıoğlu P, Ertek S.
Tirotoksikozlar – Graves Hastalığı.
In: Taylan Kabalak’ın Tiroid Hastalıkları.
Editors: Çetinkalp Ş, Özgen AG.
İstanbul Tıp Kitabevi; 2019. İstanbul.

C.2.2. Ertek S.
Diabetes mellitus’un makrovasküler komplikasyonları.
In: Türk Diyabet Yıllığı 2014–2015 (Year Book of Turkish Diabetology).
Editor: Çorapçıoğlu D.
Türk Diyabet Vakfı; 2015.

D. Ulusal Hakemli Dergilerde Yayımlanan Makaleler

D1. Ertek S, Karatan O.
The role and importance of omega-3 fatty acids in renal diseases (Omega-3 yağ asitlerinin böbrek hastalıklarının tedavisindeki yeri ve önemi).
Ankara Üniversitesi Tıp Fakültesi Mecmuası, 2004; 57: 249–255.

D2. Ertek S, Arat M, İdilman R, Ekinci C, Beksaç M.
Fatal fulminant hepatic failure during treatment of multiple myeloma.
Ankara Üniversitesi Tıp Fakültesi Mecmuası, 2005; 3: 146–148.

D3. Cesur A, Aylı M, Ertek S.
The association between calcium dobesilate and pancytopenia in type 2 diabetes: A case report.
Turkish J Hematol, 2011; 28: 77–78.

D4. Ertek S.
Endokrinolojide tele-sağlık ve tele-tıp uygulamaları.
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, 2011; 2: 126–130.

D5. Ertek S, Cicero AF, Erdoğan G.
Birinci saat hiperglisemisi olan normolipidemik hastalarda alkole bağlı olmayan yağlı karaciğer hastalığı ile ilişkili faktörler.
TurkJEM, 2012; 16: 85–88.

D6. Uyar M, Sezer S, Arat Z, Haberal M, Ertek S, Özdemir FN.
Periton diyalizi ve hemodiyaliz uygulanan hastalarda plazma ghrelin düzeyinin malnütrisyonla ilişkisi.
Türkiye Klinikleri Nefroloji Dergisi, 2013; 8: 39–46.

D7. Ertek S.
Diabetes mellitusun makrovasküler komplikasyonları.
Türkiye Klinikleri Endokrinoloji Özel Konular, 2015; 8(1): 53–60.

D8. Ertek S.
Akromegali ve yaşam kalitesi.
Türkiye Klinikleri Özel Konular, 2016; 9(1): 84–88.

D9. Ertek Yalçın S.
Kronik böbrek hastalığında dislipidemi.
Türkiye Klinikleri Özel Konular, 2018; 11(1): 105–110.

E. Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitaplarında Basılan Bildiriler

E1. Ercan EA, Kutuk U, Ertek S, Cesur M, Erkan AF, Cehreli S, Töre HF, Erdoğan G, Candan I.
Ötiroid Hashimoto tiroiditi olan hastalarda otonom sinir sistemi fonksiyonları ve global sol ventrikül performansının değerlendirilmesi: Ötiroid düzeyde tedavi gerekli midir?
XXIV. Ulusal Kardiyoloji Kongresi, Ekim 2008; Antalya.

E2. Çağlar O, Sancak T, Ertek S, Öztürk E.
Paratiroid adenomu ve tiroid papiller karsinomu birlikteliği: Olgu sunumu.
30. Ulusal Radyoloji Kongresi (TURKRAD 2009), Kasım 2009; Antalya.

E3. Ertek S, Ünlü Ersoy R, Anıl C, Demir Ö, Erdoğan MF, Gürsoy A, Güllü S, Berker D, Gül K, Ünlütürk U, Şahlı Z, Alhan A, Erdoğan G (Ankara Tiroid Grubu).
Hemitiroidektomize hastalarda kalan tiroid lobunda yeni nodül gelişimi, kalan lob ve nodül hacimlerinde artış ve hipotiroidi riski.
4. Türkiye Tiroid Kongresi, Nisan 2010; İstanbul.

E4. Erdoğan MF, Demir Ö, Ersoy RU, Gül K, Alphan Z, Mete T, Ünlütürk U, Anıl C, Ertek S, Çakır B, Aral Y, Güler S, Gürsoy A, Erdoğan G.
Graves orbitopatisinin seyrinde erken total tiroidektominin rolü.
4. Türkiye Tiroid Kongresi, Nisan 2010; İstanbul.

E5. Ertek S, Erdoğan G.
Glukoz tolerans testinde 1. saat hiperglisemisi olan hastalarda alkole bağlı olmayan yağlı karaciğer hastalığı ile ilişkili faktörler.
33. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Ekim 2011; Belek, Antalya.

E6. Yılmaz NC, Ertek S, Demiröz A, İzol AN, Üzüm AK, Harmancı A.
Tiroid ince iğne aspirasyonlarında kliniklere göre yeterlilik oranları.
33. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Ekim 2011; Belek, Antalya.

E7. Yılmaz NC, Ertek S, Vurupalmaz O.
Tiroid ince iğne aspirasyonlarının CellPrep Plus sıvı bazlı sitoloji sistemi ve konvansiyonel değerlendirmesinin yeterlilik yönünden karşılaştırılması.
33. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Ekim 2011; Belek, Antalya.

E8. Can N, Ertek S, Demiröz AS, Üzüm AK, Tarini Z, Vurupalmaz O, Mil D, Torun AN, Koçarslan S.
Güneydoğu Anadolu Bölgesi’nde foliküler varyant papiller tiroid karsinomu insidansı: Şanlıurfa Eğitim ve Araştırma Hastanesi serisi.
21. Ulusal Patoloji Kongresi, Kasım 2011; İzmir.

E9. Can N, Ertek S, Demiröz AS, Vurupalmaz O, Tarini Z.
Nonneoplastik nadir intratiroidal lezyonlar: 3 olgu sunumu.
21. Ulusal Patoloji Kongresi, Kasım 2011; İzmir.

E10. Ertek S, Yılmaz NC, Vurupalmaz Ö, Gediz Özdemirkıran F.
İmmün yetmezliği olmayan kadın hastada tiroid nodülünde Aspergillus: Olgu sunumu.
34. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Nisan 2012; Antalya.

E11. Ertek S, Yılmaz NC, Vurupalmaz Ö, Erdoğan G.
Güneydoğu Anadolu’da artan foliküler varyant papiller tiroid kanseri tanısı: Şanlıurfa Eğitim ve Araştırma Hastanesi’ndeki foliküler varyant ve klasik papiller tiroid kanseri vakalarının özelliklerinin karşılaştırılması.
34. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Nisan 2012; Antalya.

E12. Ertek S, Ay S, Cüzdan N, Koldaş Ş, Evcik D, Erdoğan G.
Komplikasyonsuz tip 2 diyabet hastalarında Kinetic Ability Trainer (KAT)-4000 ve evde yapılan egzersizlerin üç ayrı denge testi ile karşılaştırılması.
34. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Nisan 2012; Antalya.

E13. Ertek S.
Şanlıurfa Eğitim ve Araştırma Hastanesi takibindeki tip 2 diyabet hastalarında ilaç kullanımında uyumsuzluk nedenleri ve hastalık değerlendirme parametreleri.
34. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Nisan 2012; Antalya.

F. Atıfta Bulunan Yayınlar

Google Scholar (Google Akademik) taramasına göre makalelere toplam 1398 atıf bulunmaktadır.
H-indeksi: 20 (24 Eylül 2021 tarihli tarama sonucu)
🔗 https://scholar.google.com/citations?user=8sVPZPQAAAAJ&hl=tr&oi=ao